Sound Income Strategies’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63K | Sell |
5
-5
| -50% | -$2.63K | ﹤0.01% | 1219 |
|
|
2025
Q1 | $6.35K | Hold |
10
| – | – | ﹤0.01% | 1013 |
|
|
2024
Q4 | $7.12K | Hold |
10
| – | – | ﹤0.01% | 925 |
|
|
2024
Q3 | $10.5K | Hold |
10
| – | – | ﹤0.01% | 777 |
|
|
2024
Q2 | $10.5K | Hold |
10
| – | – | ﹤0.01% | 762 |
|
|
2024
Q1 | $9.63K | Sell |
10
-10
| -50% | -$9.63K | ﹤0.01% | 762 |
|
|
2023
Q4 | $17.6K | Buy |
20
+6
| +43% | +$5.27K | ﹤0.01% | 615 |
|
|
2023
Q3 | $11.5K | Sell |
14
-3
| -18% | -$2.47K | ﹤0.01% | 554 |
|
|
2023
Q2 | $12.2K | Buy |
17
+3
| +21% | +$2.16K | ﹤0.01% | 533 |
|
|
2023
Q1 | $11.5K | Sell |
14
-8
| -36% | -$6.57K | ﹤0.01% | 522 |
|
|
2022
Q4 | $15.9K | Sell |
22
-10
| -31% | -$7.22K | ﹤0.01% | 429 |
|
|
2022
Q3 | $22K | Sell |
32
-37
| -54% | -$25.4K | ﹤0.01% | 346 |
|
|
2022
Q2 | $41K | Hold |
69
| – | – | 0.01% | 243 |
|
|
2022
Q1 | $48K | Buy |
69
+36
| +109% | +$25K | 0.01% | 238 |
|
|
2021
Q4 | $21K | Hold |
33
| – | – | ﹤0.01% | 357 |
|
|
2021
Q3 | $20K | Buy |
33
+31
| +1,550% | +$18.8K | ﹤0.01% | 345 |
|
|
2021
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 816 |
|
|
2021
Q1 | $946 | Hold |
2
| – | – | ﹤0.01% | 830 |
|
|
2020
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 805 |
|
|
2020
Q3 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 773 |
|